Results of the implementation of the PETHEMA LPA 99 protocol for treating children with acute promyelocytic leukemia in Bogotá, Colombia

Pardo-Gonzalez, Carlos Alberto; Lagos-Ibarra, Jimmy Javier; Linares-Ballesteros, Adriana; Sarmiento-Urbina, Isabel Cristina; Contreras-Acosta, Agustín Darío; Cabrera-Bernal, Edgar Vladimir; Uribe-Botero, Gloria Inés; Barros-García, Gisela; Aponte-Barrios, Nelson Hernando.
Rev. Fac. Med. (Bogotá) ; 69(2): e202, Apr.-June 2021. tab, graf
Artículo en Inglés | LILACS-Express | ID: biblio-1287984

Documentos relacionados

  1. Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.
  2. Idarubicin-Intensified Hematopoietic Cell Transplantation Improves Relapse and Survival of High-Risk Acute Leukemia Patients with Minimal Residual Disease.
  3. [Acute promyelocytic leukemia. Review of the literature].
  4. A Review of DNA Methylation and microRNA Expression in Recurrent Pediatric Acute Leukemia.
  5. Kinetics and Risk Factors of Relapse after Allogeneic Stem Cell Transplantation in Children with Leukemia: A Long-Term Follow-Up Single-Center Study.
  6. Prognostic role of serum cytokines and soluble HLA-G levels in children with leukemia who undergo allogeneic stem cell transplantation.
  7. Qué nos ha enseñado y qué nos queda por aprender del estudio PREDIMED
  8. Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies.
  9. Central nervous system relapse in diffuse large B lymphoma: a retrospective cohort study
  10. Sobrevida en población pediátrica con leucemia linfoblástica aguda tratada con protocolo ALLIC-BFM de quimioterapia. Revisión sistemática